Therefore, this study aimed to analyze biochemical bone markers, with particular emphasis on vitamin K-dependent proteins, in normal-weight children with PWS undergoing GH therapy and low-energy dietary intervention compared with healthy normal-weight children. This evidence concerns the gene GH1 and Prader-Willi syndrome.